894 results on '"Nowalk, Mary Patricia"'
Search Results
2. Work Attendance with Acute Respiratory Illness Before and During COVID-19 Pandemic, United States, 2018-2022
3. Societal Cost of Racial Pneumococcal Disease Disparities in US Adults Aged 50 Years or Older
4. Epidemiology of SARS-CoV-2 and COVID-19
5. Contributors
6. Cost-effectiveness of recombinant influenza vaccine compared with standard dose influenza vaccine in adults 18–64 years of age
7. Going (Anti)Viral: Improving HIV and HCV Screening and HPV Vaccination in Primary Care
8. Pneumococcal Vaccination Strategies in 50-Year-Olds to Decrease Racial Disparities: A US Societal Perspective Cost-Effectiveness Analysis
9. Cost-effectiveness of an in-development adult-formulated 21-valent pneumococcal conjugate vaccine in US adults aged 50 years or older
10. Relationship between Telework Experience and Presenteeism during COVID-19 Pandemic, United States, March-November 2020
11. Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021
12. Cost-effectiveness of an in-development adult-formulated pneumococcal vaccine in older US adults
13. Effect of mild COVID-19 on health-related quality of life
14. Cost-Effectiveness of Newly Recommended Pneumococcal Vaccination Strategies in Older Underserved Minority Adults in the USA
15. Changes in the cost‐effectiveness of pneumococcal vaccination and of programs to increase its uptake in U.S. older adults.
16. Interim Estimates of 2019–20 Seasonal Influenza Vaccine Effectiveness — United States, February 2020
17. Cost-Effectiveness of Pneumococcal Vaccination and Uptake Improvement Programs in Underserved and General Population Adults Aged < 65 Years
18. Late‐Season Influenza Vaccine Effectiveness Against Medically Attended Outpatient Illness, United States, December 2022–April 2023.
19. Differential Induction of Interferon-Stimulated Genes by Cell-Based Versus Egg-Based Quadrivalent Influenza Vaccines in Children During the 2018–2019 Season.
20. Estimating the Burden of Adult Hospitalized RSV Infection Using Local and State Data - Methodology
21. Societal Cost of Racial Pneumococcal Disease Disparities in US Adults Aged 50 Years or Older
22. Influenza Vaccine Intention After a Medically Attended Acute Respiratory Infection
23. Interim Estimates of 2018–19 Seasonal Influenza Vaccine Effectiveness — United States, February 2019
24. Differences between Frequentist and Bayesian inference in routine surveillance for influenza vaccine effectiveness: a test-negative case-control study
25. Paid Leave and Access to Telework as Work Attendance Determinants during Acute Respiratory Illness, United States, 2017-2018
26. Differential Induction of Interferon-Stimulated Genes by Cell-Based Versus Egg-Based Quadrivalent Influenza Vaccines in Children During the 2018–2019 Season
27. Work Attendance during Acute Respiratory Illness Before and During the COVID-19 Pandemic, United States, 2018-2022
28. Influence of Birth Cohort on Effectiveness of 2015–2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United States
29. Influenza Antiviral Prescribing for Outpatients With an Acute Respiratory Illness and at High Risk for Influenza-Associated Complications During 5 Influenza Seasons—United States, 2011–2016
30. Interim Estimates of 2017–18 Seasonal Influenza Vaccine Effectiveness — United States, February 2018
31. Influenza vaccine effectiveness in older adults compared with younger adults over five seasons
32. Impact of seasonal influenza vaccination in the presence of vaccine interference
33. Differential gene expression elicited by children in response to the 2015–16 live attenuated versus inactivated influenza vaccine
34. Prior-Season Vaccination and Risk of Influenza During the 2014–2015 Season in the United States
35. Interim Estimates of 2016–17 Seasonal Influenza Vaccine Effectiveness — United States, February 2017
36. A randomized controlled trial to compare immunogenicity to cell-based vs. live-attenuated influenza vaccines in children
37. 2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type
38. Using the 4 Pillars™ Practice Transformation Program to increase adolescent human papillomavirus, meningococcal, tetanus-diphtheria-pertussis and influenza vaccination
39. Cost-effectiveness and public health impact of alternative influenza vaccination strategies in high-risk adults
40. Does cost-effectiveness of influenza vaccine choice vary across the U.S.? An agent-based modeling study
41. Improving adolescent HPV vaccination in a randomized controlled cluster trial using the 4 Pillars™ practice Transformation Program
42. Part IChapter 1 - Epidemiology of SARS-CoV-2 and COVID-19
43. Vaccine effectiveness of recombinant and standard dose influenza vaccines against outpatient illness during 2018–2019 and 2019–2020 calculated using a retrospective test-negative design
44. Using the 4 Pillars™ Practice Transformation Program to increase adult Tdap immunization in a randomized controlled cluster trial
45. Reducing Racial Disparities in Influenza Vaccination Among Children With Asthma
46. Cell-Mediated Immunity Against Antigenically Drifted Influenza A(H3N2) Viruses in Children During a Vaccine Mismatch Season
47. Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014-2015
48. Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013–2014 in the United States
49. Illness Severity and Work Productivity Loss Among Working Adults With Medically Attended Acute Respiratory Illnesses: US Influenza Vaccine Effectiveness Network 2012–2013
50. Interim Estimates of 2021-22 Seasonal Influenza Vaccine Effectiveness--United States, February 2022
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.